Janice Newberry
Oncology Marketing & Commercial Sales | KOL Advocacy | HCP Marketing
With 15 years in the oncology pharmaceuticals sector, my journey reflects a commitment to advancing cancer treatment and patient care. Currently at BI, my mission is pioneering targeted therapies while fostering collaborations. My expertise in pharmaceutical marketing and strategic KOL advocacy has become a cornerstone of my approach, ensuring that diverse insights catalyze innovation within the oncology community.
At Daiichi Sankyo, I was instrumental in the foundational RML Team for DSI Oncology, propelling the regional marketing of key ADC assets in various cancer types. My role encompassed everything from KOL segmenting and speakers bureau management to congress planning and vendor partnerships, leveraging skills in active listening and new business development to drive forward our oncology portfolio. These experiences have honed my capacity to navigate complex market dynamics and deliver impactful strategies within the oncology sphere.
My previous experience includes national launches of targeted therapies, immunotherapies and antibody drug conjugates marketing in both the pre commercial and FDA approved spaces.
The most difficult thing is the decision to act, the rest is merely tenacity. -Amelia Earhart
Talk with a Talent Expert
Members of our team are available to help you speed through the hiring process.
Book a Call
Oncology Marketing & Commercial Sales | KOL Advocacy | HCP Marketing
With 15 years in the oncology pharmaceuticals sector, my journey reflects a commitment to advancing cancer treatment and patient care. Currently at BI, my mission is pioneering targeted therapies while fostering collaborations. My expertise in pharmaceutical marketing and strategic KOL advocacy has become a cornerstone of my approach, ensuring that diverse insights catalyze innovation within the oncology community.
At Daiichi Sankyo, I was instrumental in the foundational RML Team for DSI Oncology, propelling the regional marketing of key ADC assets in various cancer types. My role encompassed everything from KOL segmenting and speakers bureau management to congress planning and vendor partnerships, leveraging skills in active listening and new business development to drive forward our oncology portfolio. These experiences have honed my capacity to navigate complex market dynamics and deliver impactful strategies within the oncology sphere.
My previous experience includes national launches of targeted therapies, immunotherapies and antibody drug conjugates marketing in both the pre commercial and FDA approved spaces.
The most difficult thing is the decision to act, the rest is merely tenacity. -Amelia Earhart
Talk with a Talent Expert
Members of our team are available to help you speed through the hiring process.
Book a Call
Pangea empowers fractional work across the world for marketing and design roles.